Zenotech Laboratories (BOM:532039) 3-Year EBITDA Growth Rate : 39.00% (As of Jun. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories 3-Year EBITDA Growth Rate?

Zenotech Laboratories's EBITDA per Share for the three months ended in Jun. 2024 was ₹0.61.

During the past 12 months, Zenotech Laboratories's average EBITDA Per Share Growth Rate was -2.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 39.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 55.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zenotech Laboratories was 147.70% per year. The lowest was -64.90% per year. And the median was 17.60% per year.

Competitive Comparison of Zenotech Laboratories's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenotech Laboratories's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's 3-Year EBITDA Growth Rate falls into.

Zenotech Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Zenotech Laboratories (BOM:532039) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Zenotech Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenotech Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078

Website

http://www.zenotechlab.com

Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories Headlines

No Headlines